EGA Position On The EC's Proposal For A Falisifed Medicines Directive
The European Generic medicines Association (EGA) is the official representative body of the European generic and biosimilar pharmaceutical industry. Being an active partner to policy makers in the fight against falsified medicines, the association has welcomed the European Commission's proposal for a Directive on the falsification of medicines, but has identified two subjects within the Directive that are of specific relevance to the European generic medicines industry.
Oct 01, 2010
Pharmaceutical Technology Europe
Volume 22, Issue 10